EURONEXT:MDMA
Pharmala Biotech Holdings Inc.
- Stock
Last Close
0.11
26/07 13:55
Volume Today
15.54K
Avg: 2.03M
PE Ratio
−61.79
PFCF: −36.83
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
May '21 | May '21 | Nov '21 | Nov '21 | Feb '22 | Feb '22 | May '22 | May '22 | Aug '22 | Aug '22 | Nov '22 | Nov '22 | Feb '23 | Feb '23 | May '23 | May '23 | Aug '23 | Nov '23 | Feb '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.03 - | 0.03 0% | 0.00 89.57% | 0.00 0% | 0.04 - | 0.04 0% | 0.18 - | 0.32 73.39% | 0.04 88.44% | |||||||||||
cash conversion cycle | 5.60K - | 5.60K 0% | 24.73K 341.60% | -52.34K 311.67% | -1.87K - | -372.74 - | -140.67 62.26% | -3.37K 2,293.78% | ||||||||||||
cash per share | 0.03 - | 0.03 0% | 0.02 13.90% | 0.02 0% | 0.01 35.04% | 0.01 0% | 0.01 29.04% | 0.01 0% | 0.01 14.28% | 0.01 0% | 0.01 0.17% | 0.01 0% | 0.01 32.22% | 0.01 0% | 0.00 62.09% | 0.00 13.73% | 0.00 81.98% | |||
company equity multiplier | 1.06 - | 1.06 0% | 1.22 15.84% | 1.22 0% | 1.15 5.80% | 1.15 0% | 1.22 6.13% | 1.22 0% | 1.42 16.01% | 1.42 0% | 1.46 2.89% | 1.46 0% | 1.56 6.72% | 1.56 0% | 1.74 12.00% | 1.58 9.28% | 1.85 16.80% | |||
days of inventory outstanding | 5.51K - | 5.51K 0% | 24.13K 337.83% | 24.13K 0% | 794.57 96.71% | 794.57 - | 1.49K - | 141.16 90.52% | 3.12 97.79% | 57.95 1,756.87% | ||||||||||
days of payables outstanding | 77.07K - | 2.75K - | 2.65K - | 559.76 78.89% | 177.92 68.21% | 3.82K 2,046.11% | ||||||||||||||
days of sales outstanding | 89.46 - | 89.46 0% | 602.82 573.85% | 602.82 0% | 82.46 - | 82.46 0% | 45.85 - | 34.13 25.56% | 393.19 1,051.88% | |||||||||||
dividend yield | ||||||||||||||||||||
ebit per revenue | -2.92 - | -2.92 0% | -25.37 768.10% | -25.37 0% | -2.33 - | -2.33 0% | 0.20 - | 0.27 34.88% | -2.46 999.56% | |||||||||||
ebt per ebit | 1 - | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 0.33 66.83% | 0.33 0% | 1 201.50% | 1 0% | -0.90 190.23% | 0.18 119.63% | 1.00 464.48% | |
effective tax rate | -0.00 - | 0.00 133.18% | 2.01 - | 0.00 - | -0.00 - | |||||||||||||||
enterprise value multiple | -14.85 - | -14.85 0% | -10.99 26.00% | -10.99 0% | -6.27 42.97% | -6.27 0% | -18.27 191.52% | -18.27 0% | -4.88 73.28% | -4.88 0% | -51.16 947.66% | -51.16 0% | -83.88 63.96% | -83.88 0% | 185.83 321.54% | 36.05 80.60% | -79.66 320.95% | |||
fixed asset turnover | 16.75 - | 16.75 0% | 1.99 88.14% | 1.99 0% | 31.61 - | 31.61 0% | 208.69 - | 449.50 115.39% | 71.70 84.05% | |||||||||||
free cash flow per share | -0.00 - | -0.00 0% | -0.00 8.24% | -0.00 0% | -0.01 117.00% | -0.01 0% | -0.00 46.16% | -0.00 0% | -0.00 65.11% | -0.00 0% | -0.00 68.89% | -0.00 0% | -0.00 919.70% | -0.00 0% | -0.00 24.81% | -0.00 86.04% | -0.00 330.39% | |||
gross profit margin | 0.97 - | 0.97 0% | 0.94 3.21% | 0.94 0% | 1 - | 0.86 14.12% | 0.82 - | 0.61 25.75% | 0.83 35.18% | |||||||||||
interest coverage | 1.50 - | 1.50 0% | ||||||||||||||||||
inventory turnover | 0.02 - | 0.02 0% | 0.00 77.16% | 0.00 0% | 0.11 2,936.41% | 0.11 - | 0.06 - | 0.64 955.33% | 28.84 4,423.11% | 1.55 94.61% | ||||||||||
long term debt to capitalization | ||||||||||||||||||||
net income per ebt | 1 - | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | -1.01 201.50% | 1 198.53% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | |
net profit margin | -2.92 - | -2.92 0% | -25.37 768.10% | -25.37 0% | 0.79 - | -0.77 198.53% | -0.18 - | 0.05 126.48% | -2.46 5,177.80% | |||||||||||
operating cash flow per share | -0.00 - | -0.00 0% | -0.00 91.89% | -0.00 0% | -0.00 1,759.38% | -0.00 0% | 0.00 119.13% | 0.00 0% | -0.00 101.83% | -0.00 0% | 0.00 577.30% | 0.00 0% | -0.00 4,674.83% | -0.00 0% | -0.00 90.31% | 0.00 145.23% | -0.00 840.84% | |||
operating cycle | 5.60K - | 5.60K 0% | 24.73K 341.60% | 24.73K 0% | 877.03 - | 187.02 - | 37.26 80.08% | 451.14 1,110.94% | ||||||||||||
operating profit margin | -2.92 - | -2.92 0% | -25.37 768.10% | -25.37 0% | -2.33 - | -2.33 0% | 0.20 - | 0.27 34.88% | -2.46 999.56% | |||||||||||
payables turnover | 0.00 - | 0.03 - | 0.03 - | 0.16 373.74% | 0.51 214.61% | 0.02 95.34% | ||||||||||||||
pretax profit margin | -2.92 - | -2.92 0% | -25.37 768.10% | -25.37 0% | -0.77 - | -0.77 0% | -0.18 - | 0.05 126.48% | -2.46 5,177.80% | |||||||||||
price fair value | 2.75 - | 2.75 0% | 2.30 16.26% | 2.30 0% | 1.26 45.14% | 1.26 0% | 2.18 72.43% | 2.18 0% | 1.25 42.53% | 1.25 0% | 6.82 445.23% | 6.82 0% | 19.06 179.47% | 19.06 0% | 13.69 28.19% | 5.45 60.22% | 12.30 125.83% | |||
receivables turnover | 1.01 - | 1.01 0% | 0.15 85.16% | 0.15 0% | 1.09 - | 1.09 0% | 1.96 - | 2.64 34.33% | 0.23 91.32% | |||||||||||
return on assets | -0.12 - | -0.12 0% | -0.11 9.15% | -0.11 0% | -0.09 15.88% | -0.09 0% | -0.08 9.44% | -0.08 0% | -0.12 49.30% | -0.12 0% | 0.03 124.95% | -0.03 198.53% | -0.15 394.66% | -0.15 0% | -0.03 77.69% | 0.02 145.92% | -0.09 686.99% | |||
return on capital employed | -0.13 - | -0.13 0% | -0.13 5.25% | -0.13 0% | -0.10 20.76% | -0.10 0% | -0.10 3.89% | -0.10 0% | -0.17 73.20% | -0.17 0% | -0.13 23.74% | -0.13 0% | -0.23 75.09% | -0.23 0% | 0.06 127.70% | 0.14 112.16% | -0.17 221.45% | |||
return on equity | -0.13 - | -0.13 0% | -0.13 5.25% | -0.13 0% | -0.10 20.76% | -0.10 0% | -0.10 3.89% | -0.10 0% | -0.17 73.20% | -0.17 0% | 0.04 125.67% | -0.04 198.53% | -0.23 427.89% | -0.23 0% | -0.06 75.01% | 0.02 141.65% | -0.17 785.57% | |||
total debt to capitalization | -0.24 - | -0.32 - | -0.36 - | 0.15 142.69% | -0.62 502.26% |
All numbers in (except ratios and percentages)